These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adverse effects of switching from fluoxetine to desipramine. Van Ameringen M; Mancini C Can J Psychiatry; 1992 May; 37(4):278. PubMed ID: 1611591 [No Abstract] [Full Text] [Related]
5. Extrapyramidal symptoms upon discontinuation of fluoxetine. Stoukides JA; Stoukides CA Am J Psychiatry; 1991 Sep; 148(9):1263. PubMed ID: 1883010 [No Abstract] [Full Text] [Related]
7. Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy. Benazzi F J Psychopharmacol; 1997; 11(2):190-1. PubMed ID: 9208383 [No Abstract] [Full Text] [Related]
8. Paroxetine withdrawal syndrome. Pyke RE Am J Psychiatry; 1995 Jan; 152(1):149-50. PubMed ID: 7802108 [No Abstract] [Full Text] [Related]
9. Physical symptoms associated with paroxetine withdrawal. Debattista C; Schatzberg AF Am J Psychiatry; 1995 Aug; 152(8):1235-4. PubMed ID: 7625481 [No Abstract] [Full Text] [Related]
10. Fluoxetine for clomipramine withdrawal symptoms. Benazzi F Am J Psychiatry; 1999 Apr; 156(4):661-2. PubMed ID: 10200756 [No Abstract] [Full Text] [Related]
11. Case 2: Dizzy Giuseppi or the vertiginous virtuoso. Shader RI; Oesterheld JR J Clin Psychopharmacol; 1994 Dec; 14(6):437. PubMed ID: 7884033 [No Abstract] [Full Text] [Related]
12. The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series. Malone DA; Dimeff RJ J Clin Psychiatry; 1992 Apr; 53(4):130-2. PubMed ID: 1564048 [TBL] [Abstract][Full Text] [Related]
13. Danger of MAOI therapy after fluoxetine withdrawal. Graham PM; Ilett KF Lancet; 1988 Nov; 2(8622):1255-6. PubMed ID: 2903989 [No Abstract] [Full Text] [Related]
14. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Feighner JP J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204 [TBL] [Abstract][Full Text] [Related]
15. Fluoxetine discontinuation in elderly dysthymic patients. Devanand DP; Kim MK; Nobler MS Am J Geriatr Psychiatry; 1997; 5(1):83-7. PubMed ID: 9169249 [TBL] [Abstract][Full Text] [Related]
17. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. Chouinard G J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679 [TBL] [Abstract][Full Text] [Related]
18. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. Feighner JP; Cohn JB J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676 [TBL] [Abstract][Full Text] [Related]
19. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. Cohn JB; Wilcox C J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677 [TBL] [Abstract][Full Text] [Related]
20. Reversible delirium after discontinuation of fluoxetine. Kasantikul D J Med Assoc Thai; 1995 Jan; 78(1):53-4. PubMed ID: 7622979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]